About Bladder Cancer

Smoking and industrial chemicals raise your risk. Get more facts and connect to in-depth info.
Upper Tract Urothelial Cancer

At the GBCI, our specialized team is developing new therapies and approaches to UTUC.
Bladder Cancer Treatment

From proven protocols to promising clinical trials, you have options. We'll educate and guide you.
Our Approach to Care

A multidisciplinary team collaborates to provide customized precision care every step of the way.
Grand Rounds Educational Series

View recordings of past webinars or register for our newly announced Fall/Winter 2022 Zoom sessions.
Women & Bladder Cancer

Learn more about our Women's Bladder Cancer Program, or register for our upcoming women-run support groups.

APPOINTMENTS In-person clinical appointments

The Greenberg Bladder Cancer Institute offers in-person clinical appointments for newly diagnosed bladder cancer, bladder cancer which has recurred (sometimes referred to as metastasized) and upper tract urothelial cancer (commonly referred to as UTUC). We have specialized clinical programs to serve patients and families at all stages of bladder cancer. We are unable to do telemedicine consults or informally comment on a treatment plan. To start the process of seeing our bladder cancer team or our upper tract urothelial team, please send us an email using the menu to the right.

Meet Our Team

Meet Our Director

David J. McConkey, Ph.D. is the inaugural director of the Johns Hopkins Greenberg Bladder Cancer Institute and Professor in the Department of Urology at Johns Hopkins Medicine. His mission is to make the Institute a hub of an institutional and international community of researchers who share a commitment to advancing the scientific understanding of bladder cancer and improving its treatment.